Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
2 Months : From Nov 2019 to Jan 2020
By Stephen Nakrosis
Shares of Eagle Pharmaceuticals, Inc. (EGRX) are trading higher in Friday's market, after the company said it reached a settlement agreement with Eli Lilly and Co. (LLY) related to Pemfexy.
At 3:01 p.m. EST, Eagle Pharma shares had risen 2.77%, to trade at $60.78. The stock opened at $59.04 and earlier in the session fell as low as $58.54.
According to Eagle, the agreement releases all claims by all parties and allows for an initial entry of Pemfexy, a branded alternative to Alitma, into the market on February 1, 2022. Under the terms of the deal, Pemfexy will have an uncapped entry into the market on April 1 of that year, Eagle said.
--Write to Stephen Nakrosis at email@example.com
(END) Dow Jones Newswires
December 13, 2019 15:22 ET (20:22 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.